B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LARGE1

MOLECULAR TARGET

LARGE xylosyl- and glucuronyltransferase 1

UniProt: O95461NCBI Gene: 92151 compounds

LARGE1 (LARGE xylosyl- and glucuronyltransferase 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LARGE1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Methylene Blue0.691

About LARGE1 as a Drug Target

LARGE1 (LARGE xylosyl- and glucuronyltransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented LARGE1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LARGE1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.